Contents of Volume 83, 2019
Total Page:16
File Type:pdf, Size:1020Kb
ii Contents of Volume 83, 2019 CONTENTS OF VOLUME 83, 2019 Message From the Editor-in-Chief 1. Message From the Editor-in-Chief Toyoaki Murohara ········ 1 2. Editorial Statistics and Best Reviewers Award for 2018 Toyoaki Murohara ········ 249 3. Circulation Journal Awards for the Year 2018 Toyoaki Murohara ········ 495 4. Rapid Publication and Announcement of the 2019 JCS Meeting Activities Toyoaki Murohara ········ 695 5. Announcement of the 2019 JCS Meeting Activities (2) Toyoaki Murohara ········ 949 6. Message From the Editor-in-Chief Toyoaki Murohara ········ 1421 7. Message From the Editor-in-Chief Toyoaki Murohara ········ 1621 8. Message From the Editor-in-Chief Toyoaki Murohara ········ 1811 In Memoriam 1. Tribute to Dr. John Ross Jr Shigetake Sasayama ········ 1817 2. Kazuo Yamada, MD, PhD ― 1924–2019 ― Junji Toyama ········ 2189 3. Tribute to Paul M. Vanhoutte, MD, PhD ― 1940–2019 ― Hiroaki Shimokawa, Tetsuhiko Nagao, Kimihiro Komori ········ 2391 JCS Statement 1. Standard Cardiac Rehabilitation Program for Heart Failure Hideo Izawa, Toshiko Yoshida, Toshimi Ikegame, Kazuhiro P. Izawa, Yoshihiro Ito, Hideo Okamura, Naohiko Osada, Shintaro Kinugawa, Takuro Kubozono, Yuji Kono, Kiyonori Kobayashi, Kazuhiko Nishigaki, Taiki Higo, Akihiro Hirashiki, Yasushi Miyazawa, Yuji Morio, Masanobu Yanase, Sumio Yamada, Hisao Ikeda, Shin-ichi Momomura, Yasuki Kihara, Kazuhiro Yamamoto, Yoichi Goto, Shigeru Makita, the Japanese Association of Cardiac Rehabilitation Standard Cardiac Rehabilitation Program Planning Committee ········ 2394 Reviews 1. Clonal Hematopoiesis and Its Impact on Cardiovascular Disease Soichi Sano, Ying Wang, Kenneth Walsh ········ 2 2. Discovery of a Vascular Endothelial Stem Cell (VESC) Population Required for Vascular Regeneration and Tissue Maintenance Nobuyuki Takakura ········ 12 3. Ivabradine for the Treatment of Cardiovascular Diseases Tomomi Ide, Kisho Ohtani, Taiki Higo, Makoto Tanaka, Yasushi Kawasaki, Hiroyuki Tsutsui ········ 252 4. Corticotropin-Releasing Hormone Family and Their Receptors in the Cardiovascular System Mikito Takefuji, Toyoaki Murohara ········ 261 5. ANGPTL3 Inhibitors ― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ― Eleni Geladari, Panagiota Tsamadia, Natalia G. Vallianou ········ 267 6. Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines? ― An Asian Perspective ― Sang-Hyun Ihm, George Bakris, Ichiro Sakuma, Il Suk Sohn, Kwang Kon Koh ········ 504 7. Autophagy in the Heart Osamu Yamaguchi ········ 697 Circulation Journal Vol.83, December 2019 Contents of Volume 83, 2019 iii 8. Current Key Issues in Transcatheter Aortic Valve Replacement Undergoing a Paradigm Shift In-Chang Hwang, Kentaro Hayashida, Hyo-Soo Kim ········ 952 9. Autologous CD34+ Cell Therapy for Ischemic Tissue Repair William K. Sietsema, Atsuhiko Kawamoto, Hiroshi Takagi, Douglas W. Losordo ········ 1422 10. Immune Disorder in Atherosclerotic Cardiovascular Disease ― Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers ― Rajib Neupane, Xiongjie Jin, Takeshi Sasaki, Xiang Li, Toyoaki Murohara, Xian Wu Cheng ········ 1431 11. Utilization of Artificial Intelligence in Echocardiography Kenya Kusunose, Akihiro Haga, Takashi Abe, Masataka Sata ········ 1623 12. Nationwide Actions Against Heart Failure Pandemic in Japan ― What Should We Do From Academia? ― Issei Komuro, Hidehiro Kaneko, Hiroyuki Morita, Mitsuaki Isobe, Hirofumi Nakayama, Kazuo Minematsu, Takenori Yamaguchi, Yoshio Yazaki ········ 1819 13. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention Sho-ichi Yamagishi ········ 1822 14. Strategies to Overcome Residual Risk During Statins Era Kyoung Im Cho, Jongwook Yu, Toshio Hayashi, Seung Hwan Han, Kwang Kon Koh ········ 1973 15. Effects of Tobacco Smoking on Cardiovascular Disease Takahisa Kondo, Yoshihisa Nakano, Shiro Adachi, Toyoaki Murohara ········ 1980 16. The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan Yuji Okura, Kazuyuki Ozaki, Hiroshi Tanaka, Tatsuya Takenouchi, Nobuaki Sato, Tohru Minamino ········ 2191 17. Function Follows Form ― A Review of Cardiac Cell Therapy ― Kenta Nakamura, Charles E. Murry ········ 2399 Congress Reports 2018 ESC Report 1. European Society of Cardiology (ESC) Annual Congress Report From Munich 2018 Yasutsugu Shiono, Takashi Akasaka ········ 18 2019 JCS Report 2. Overview of the 83rd Annual Scientific Meeting of the Japanese Circulation Society ― Renaissance of Cardiology for the Creation of Future Medicine ― Hiroshi Akazawa, Haruhiro Toko, Mutsuo Harada, Kazutaka Ueda, Satoshi Kodera, Arihiro Kiyosue, Katsuhito Fujiu, Masaru Hatano, Masao Daimon, Jiro Ando, Eiki Takimoto, Hiroyuki Morita, Issei Komuro ········ 1829 Editorials 1. Does the Cardiac Surgeon Accept Coronary Artery Bypass Grafting With Incomplete Revascularization for Patients With Low Ventricular Function and Complex Multivessel Coronary Disease? Shinya Takase ········ 25 2. Gender Difference in the Association Between Uric Acid and Atrial Fibrillation Masanari Kuwabara, Ichiro Hisatome ········ 27 3. Altered Gut Flora and Gut Microbiome-Derived Metabolites in Heart Failure Patients in the Compensated and Decompensated Phases Akiomi Yoshihisa ········ 30 4. Heart Failure Mid-Range Ejection Fraction ― Heart Failure With Multiple Personalities ― Shin-ichi Momomura, Miyuki Ito ········ 274 5. Beneficial Prognostic Effects of Statins in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients ― HFpEF as a Manifestation of Systemic Disease ― Tatsuo Aoki ········ 277 6. Novel Echocardiographic Parameter in Heart Failure Is Born Naoyuki Yokoyama ········ 279 7. Oral β-Blocker Therapy in Acute Myocardial Infarction Neiko Ozasa, Takeshi Kimura ········ 281 8. Unexpected, But Reasonable Association Between Anderson-Fabry Disease and Coronary Vasospasm Tetsuya Matoba, Yasuhiro Nakano, Hiroyuki Tsutsui ········ 283 9. Crosstalk Between the Heart and Blood in Heart Failure Naoki Sato ········ 511 Circulation Journal Vol.83, December 2019 iv Contents of Volume 83, 2019 10. C-Reactive Protein and Chronic Inflammation ― Is It a Novel Therapeutic Target for Subsequent Cancer Death in Patients With Coronary Artery Disease? ― Hidehiro Kaneko, Issei Komuro ········ 513 11. How Is Uric Acid Related to Atrial Fibrillation? Katsushige Ono ········ 705 12. Underdosing of Direct Oral Anticoagulants ― Pros or Cons? ― Moritake Iguchi, Masaharu Akao ········ 707 13. Genetic Prediction of Atherosclerosis ― Significance of Polymorphisms in Bone Morphogenetic Protein Signaling Molecule Genes ― Mari Ishida ········ 709 14. Coffee Drinking and Risk of All-Cause Mortality and Cardiovascular Diseases Yoichiro Hirakawa ········ 711 15. Importance of Risk Stratification After Myocardial Infarction and the Need for Its Clinical Application Seung Hwan Han, Kwang Kon Koh ········ 713 16. Self-Efficacy and Physical Activity Level Holds Important Implications for Transfer of Adult Congenital Heart Disease Takashi Miyamoto ········ 715 17. A Main Performer May Come for Percutaneous Coronary Intervention With Atrial Fibrillation in Japanese Patients Ken Kozuma ········ 963 18. Years of Life Lost Analysis May Promote Governmental Policy to Prevent Atherosclerotic Cardiovascular Disease Yoshiyuki Ikeda, Mitsuru Ohishi ········ 965 19. Clinical Impact and Significance of Serum Lipoprotein (a) Levels on Cardiovascular Risk in Patients With Coronary Artery Disease Hiroshi Yoshida ········ 967 20. Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease Hirotoshi Ohmura ········ 969 21. Low Endothelial Sheer Stress ― A Silent Killer ― Shichiro Abe, Setsu Nishino, Masashi Sakuma, Teruo Inoue ········ 1197 22. First Hospitalization Tells Us Everything About Heart Failure Shintaro Kinugawa, Arata Fukushima ········ 1200 23. Atrial Fibrillation Does Not Matter in Japanese Ventricular Assist Device Patients? ― Half-Way Up the Hill ― Toshiyuki Nagai, Toshihisa Anzai ········ 1202 24. Renin Activity as a Key Predictor of Major Adverse Cardiac Events Takahisa Kondo, Yoshihisa Nakano, Shiro Adachi, Toyoaki Murohara ········ 1204 25. Vascular Senescense and Endothelial Function ― Can We Apply It to Atrial Fibrillation? ― Toshio Hayashi ········ 1439 26. Is Working at a Small Company a Component of “The Status Syndrome” in Japan? Isao Saito ········ 1441 27. Activin A ― A Potentially Useful Biomarker of Diastolic Dysfunction ― Satoshi Masutani ········ 1443 28. Insights From 10-Year Outcomes of Mesenchymal Stem Cell Transplantation in Heart Failure Patients Oto Inoue, Masayuki Takamura ········ 1446 29. Newer Specific Risk Scores for Outcome After Transcatheter Aortic Valve Replacement Noriaki Tabata, Kenichi Tsujita ········ 1630 30. Kidney Measures to Improve Risk Discrimination of Cardiovascular Events Hideki Ishii, Toyoaki Murohara ········ 1836 31. Worsening of Left Ventricular Diastolic Function Is Associated With Adverse Outcomes in Patients With Coronary Artery Disease Satoshi Yuda ········ 1838 32. Risk Factors for Major Amputation in the Japanese Population ― How Can We Predict and Prevent Lower Limb Loss in Patients With Peripheral Arterial Disease? ― Toshifumi Kudo ········ 1840 33. You Want to See a Female Doctor ― But Unluckily There's a Lack in Japan ― Yuko Inoue, Chisato Izumi ········ 1842 34. How Do We Improve the Utility of Fractional Flow Reserve? ― For Precise Diagnosis